Form 4: Encompass Health Director Kevin J. O'Connor Acquires Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4


Director Kevin J. O'Connor received 14 shares of Encompass Health stock through a dividend reinvestment program.

Summary

  • Kevin J. O'Connor, a director at Encompass Health Corp, acquired 14 shares of common stock on January 15, 2025.
  • The shares were awarded as restricted stock units (RSUs) in connection with a common stock dividend payment.
  • The dividend was $0.17 per share, and the closing price of Encompass Health stock on the dividend payment date was $93.61.
  • The RSUs were credited to O'Connor's account based on the dividend payment and the closing stock price.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation and dividend reinvestment, which is generally viewed positively as it aligns director interests with shareholders.

Positives

  • The acquisition of shares through dividend reinvestment indicates a continued investment in the company by a director.
  • The dividend payment demonstrates a return of value to shareholders.

Industry Context

This is a routine transaction related to director compensation and dividend reinvestment, which is common practice for publicly traded companies.

Comparison to Industry Standards

  • Dividend reinvestment programs are a common practice among publicly listed companies, including those in the healthcare sector like Encompass Health.
  • Companies such as Select Medical Holdings and HCA Healthcare also offer similar programs for their directors and employees.
  • The amount of shares acquired is dependent on the dividend amount and the stock price on the payment date, which is standard practice.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it demonstrates director alignment with company performance.
  • The dividend payment provides a return to shareholders.

Key Dates

DateDescription
01/15/2025Date of the transaction where Kevin J. O'Connor acquired shares through dividend reinvestment.
01/17/2025Date the Form 4 was signed by Patrick Darby, attorney-in-fact for Kevin J. O'Connor.

Keywords

Encompass Health, Director, Kevin J. O'Connor, Dividend Reinvestment, Restricted Stock Units, RSUs, Share Acquisition, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.